These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 28495314)
1. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses. Won G; Kim B; Lee JH Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314 [TBL] [Abstract][Full Text] [Related]
2. Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective inactivated vaccine candidate against fowl typhoid. Jawale CV; Chaudhari AA; Lee JH Vaccine; 2014 Feb; 32(9):1093-9. PubMed ID: 24406393 [TBL] [Abstract][Full Text] [Related]
3. Construction of an inactivated typhoid vaccine candidate expressing Kim B; Won G; Lee JH J Med Microbiol; 2017 Aug; 66(8):1235-1243. PubMed ID: 28792376 [No Abstract] [Full Text] [Related]
4. A novel approach for the generation of Salmonella Gallinarum ghosts and evaluation of their vaccine potential using a prime-booster immunization strategy. Jawale CV; Lee JH Vaccine; 2014 Nov; 32(50):6776-82. PubMed ID: 25454861 [TBL] [Abstract][Full Text] [Related]
5. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110 [TBL] [Abstract][Full Text] [Related]
6. Vi Capsular Polysaccharide Produced by Recombinant Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685 [TBL] [Abstract][Full Text] [Related]
7. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses. Das S; Chowdhury R; Ghosh S; Das S Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115 [TBL] [Abstract][Full Text] [Related]
8. Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens. Chaudhari AA; Jawale CV; Kim SW; Lee JH Vet Res; 2012 May; 43(1):44. PubMed ID: 22620989 [TBL] [Abstract][Full Text] [Related]
9. Generation of a safe Salmonella Gallinarum vaccine candidate that secretes an adjuvant protein with immunogenicity and protective efficacy against fowl typhoid. Nandre RM; Lee JH Avian Pathol; 2014; 43(2):164-71. PubMed ID: 24689430 [TBL] [Abstract][Full Text] [Related]
10. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever. Das S; Chowdhury R; Pal A; Okamoto K; Das S Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553 [TBL] [Abstract][Full Text] [Related]
11. Characterization of adaptive immune responses induced by a new genetically inactivated Salmonella Enteritidis vaccine. Jawale CV; Lee JH Comp Immunol Microbiol Infect Dis; 2014 May; 37(3):159-67. PubMed ID: 24878070 [TBL] [Abstract][Full Text] [Related]
12. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216 [TBL] [Abstract][Full Text] [Related]
13. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460 [TBL] [Abstract][Full Text] [Related]
14. An immunogenic Salmonella ghost confers protection against internal organ colonization and egg contamination. Jawale CV; Lee JH Vet Immunol Immunopathol; 2014 Nov; 162(1-2):41-50. PubMed ID: 25241048 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system. Jawale CV; Chaudhari AA; Jeon BW; Nandre RM; Lee JH Infect Immun; 2012 Apr; 80(4):1502-9. PubMed ID: 22290147 [TBL] [Abstract][Full Text] [Related]
16. Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice. Halder P; Maiti S; Banerjee S; Das S; Dutta M; Dutta S; Koley H Vaccine; 2023 Sep; 41(41):5994-6007. PubMed ID: 37625993 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice. Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620 [TBL] [Abstract][Full Text] [Related]
18. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae. Pakkanen SH; Kantele JM; Herzog C; Kantele A Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246 [TBL] [Abstract][Full Text] [Related]
19. A novel method to generate Salmonella Typhi Ty21a ghosts exploiting the λ phage holin-endolysin system. Won G; Kim B; Lee JH Oncotarget; 2017 Jul; 8(29):48186-48195. PubMed ID: 28637001 [TBL] [Abstract][Full Text] [Related]
20. Differential functional patterns of memory CD4 Salerno-Gonçalves R; Tettelin H; Luo D; Guo Q; Ardito MT; Martin WD; De Groot AS; Sztein MB Vaccine; 2020 Jan; 38(2):258-270. PubMed ID: 31629569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]